Cargando…
Decrease of prostaglandin I2 binding sites in thyroid cancer.
The properties of specific prostaglandin I2 (prostacyclin, PGI2) binding sites in normal thyroid tissue have been characterised. Tissue samples obtained intraoperatively from patients with 'cold' solitary thyroid nodules (as preoperatively selected by thyroid gland scintigraphy, thyroid gl...
Autores principales: | Virgolini, I., Hermann, M., Sinzinger, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246842/ https://www.ncbi.nlm.nih.gov/pubmed/2464364 |
Ejemplares similares
-
Human hepatocellular cancers show decreased prostaglandin E1 binding capacity.
por: Virgolini, I., et al.
Publicado: (1989) -
Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
por: Virgolini, I., et al.
Publicado: (1990) -
Comparison of PGH(2 )binding site in prostaglandin synthases
por: Paragi-Vedanthi, Padmapriya, et al.
Publicado: (2010) -
Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.
por: Virgolini, I., et al.
Publicado: (1993) -
Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.
por: Li, S. R., et al.
Publicado: (1993)